Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PHH logo PHH
Upturn stock ratingUpturn stock rating
PHH logo

Park Ha Biological Technology Co., Ltd. (PHH)

Upturn stock ratingUpturn stock rating
$12.6
Delayed price
Profit since last BUY87.78%
upturn advisory
Strong Buy
BUY since 19 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: PHH (3-star) is a STRONG-BUY. BUY since 19 days. Profits (87.78%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 87.78%
Avg. Invested days 19
Today’s Advisory Strong Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 310.95M USD
Price to earnings Ratio 589.5
1Y Target Price 15
Price to earnings Ratio 589.5
1Y Target Price 15
Volume (30-day avg) 472
Beta -
52 Weeks Range 3.67 - 13.63
Updated Date 04/1/2025
52 Weeks Range 3.67 - 13.63
Updated Date 04/1/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.02

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 20.09%
Operating Margin (TTM) 45.87%

Management Effectiveness

Return on Assets (TTM) 18.55%
Return on Equity (TTM) 38%

Valuation

Trailing PE 589.5
Forward PE -
Enterprise Value 348719915
Price to Sales(TTM) 130.55
Enterprise Value 348719915
Price to Sales(TTM) 130.55
Enterprise Value to Revenue 146.41
Enterprise Value to EBITDA 427.14
Shares Outstanding 26374400
Shares Floating 4824406
Shares Outstanding 26374400
Shares Floating 4824406
Percent Insiders 81.71
Percent Institutions 0.3

Analyst Ratings

Rating -
Target Price 15
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

About Park Ha Biological Technology Co., Ltd.

Exchange NASDAQ
Headquaters -
IPO Launch date 2024-12-27
CEO & Chairman of the Board Ms. Xiaoqiu Zhang
Sector Consumer Defensive
Industry Household & Personal Products
Full time employees 17
Full time employees 17

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​